share_log

Needham Reiterates Buy on RxSight, Announces $66 Price Target

Benzinga ·  Jan 13 10:40  · Ratings

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and announces $66 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 336

Recommended

Write a comment